SAN DIEGO, Aug. 30 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq:
CRYO), a medical device company focused on the treatment of cardiac
arrhythmias, announced today that Edward F. Brennan, President and Chief
Executive Officer, and Gregory J. Tibbitts, Chief Financial Officer, are
scheduled to present at the Roth Capital Partners 5th Annual New York
Conference in New York, NY on Thursday, September 6, 2007 at 12:00 p.m. ET
at The Westin New York at Times Square.
A live Web cast and recording of the presentation will be available
online from the investor relations page of the Company's corporate Web site
at http://www.cryocor.com. The recording will remain available on CryoCor's
Web site for at least 30 days following presentation.
About CryoCor
CryoCor is a medical technology company that has developed and
manufactures a disposable catheter system based on its proprietary
cryoablation technology for the minimally invasive treatment of cardiac
arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation
System, or the Cryoablation System, is designed to treat cardiac
arrhythmias through the use of cryoenergy, or extreme cold, to destroy
targeted cardiac tissue. The Cryoablation System has been approved in
Europe for the treatment of atrial fibrillation, and atrial flutter, the
two most common and difficult to treat arrhythmias, since 2002. In the
United States, CryoCor is conducting a pivotal trial to evaluate the safety
and efficacy of the Cryoablation System for the treatment of atrial
fibrillation and the Cryoablation System has been approved for the
treatment of right atrial flutter. For more information please visit the
Company's website at http://www.cryocor.com
Forward Looking Statements
The statements in this press release that are not descriptions of
historical facts are forward-looking statements that are subject to risks
and uncertainties. The actual events or results may differ materially from
those projected in such forward-looking statements due to a number of
factors and the risks and uncertainties identified in the Company's filings
with the Securities and Exchange Commission. These forward-looking
statements speak only as of the date hereof. The Company expressly
disclaims any intent or obligation to update any of these forward-looking
statements.
Contact:
CryoCor, Inc. The Ruth Group
Gregory J. Tibbitts Nick Laudico / Zack Kubow (investors)
Chief Financial Officer (646) 536-7030 / 7020
(858) 909-2200 nlaudico@theruthgroup.com
gtibbitts@cryocor.com zkubow@theruthgroup.com
Jason Rando (media)
(646) 536-7025
jrando@theruthgroup.com
SOURCE CryoCor, Inc.
 back to top
Related links:
http://www.cryocor.com
http://www.rothconference.com
http://www.prnewswire.com/comp/159222.html /
CONTACT:
Gregory J. Tibbitts, Chief Financial Officer,
CryoCor, Inc., +1-858-909-2200, gtibbitts@cryocor.com; or
investors, Nick Laudico, +1-646-536-7030,
nlaudico@theruthgroup.com, or Zack Kubow, +1-646-536-7020,
zkubow@theruthgroup.com, or media, Jason Rando, +1-646-536-7025,
jrando@theruthgroup.com, all of The Ruth Group, for CryoCor
|
